Comparison of eptinezumab 300 mg with 100 mg for the treatment of migraine: a meta-analysis of randomized controlled studies
Sign Up to like & getrecommendations! Published in 2024 at "African Health Sciences"
DOI: 10.4314/ahs.v24i3.43
Abstract: Introduction The efficacy and safety of eptinezumab 300 mg versus 100 mg for migraine remains debatable. We conduct this meta-analysis to compare eptinezumab 300 mg with 100 mg on the treatment of migraine. Methods We… read more here.
Keywords: migraine; 100 treatment; meta analysis; eptinezumab 300 ... See more keywords